Hosted on MSN

Zydus to develop combination vaccine for shigellosis and typhoid

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with support from the Gates Foundation, will carry out ...
Morningstar

Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.

AHMEDABAD, India and PENNINGTON, N.J., Jan. 15, 2026 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as ...

Agenus Rises After Triggering First $20M Payment Under Zydus Collaboration

Shares of Agenus climbed after the clinical-stage immuno-oncology company triggered the first $20 million contingent payment under its strategic collaboration with Zydus Lifesciences. The stock jumped ...
GEN

Agenus Closes Strategic Immunotherapeutic Collaboration with Zydus Lifesciences

Agenus closed its previously disclosed $141 million strategic collaboration with Zydus Lifesciences, which is designed to accelerate global development and potential commercialization of Agenus’s ...
The Caledonian-Record

Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has triggered the first $20 million contingent payment under its previously disclosed strategic ...
Nasdaq

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership ...